Table: Modalis Therapeutics -2021 group results

Modalis Therapeutics

14/02/2022 06:01

Feb 14 (Reuters)- 
          Modalis Therapeutics Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           1 mln          342 mln                               
               (-99.7 pct)     (-46.9 pct)                             
  Operating     loss 1.24     loss 398 mln                             
  Recurring     loss 1.23     loss 439 mln                             
  Net
  Net         loss 738 mln    loss 448 mln                             
  EPS        loss 25.70 yen  loss 17.02 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Modalis Therapeutics Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T